Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. MANTADIX (amantadine (chlorhydrate d’))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

MANTADIX (amantadine (chlorhydrate d’))

Medicine - Posted on Sep 08 2023
Active substance (DCI)
  • amantadine (chlorhydrate d’)
history (5)
  • 8/30/23

    MANTADIX (chlorhydrate d'amantadine) - Maladie de Parkinson

    Inscription : Primo-inscription. L'essentiel Avis favorable au remboursement uniquement dans le « traitement des dyskinésies...
    CAV :
    54321
    icône flèche
  • 7/7/21

    MANTADIX (amantadine)

    Arrêt du remboursement dans l’indication « syndromes parkinsoniens induits par les neuroleptiques ». Avis favorable à l’arrê...
    icône flèche
  • 7/7/21

    MANTADIX (amantadine)

    Key points Favourable opinion for reimbursement in the treatment of levodopa-induced dyskinesia in patients with Parkinson’s...
    CAV :
    54321
    icône flèche
  • 5/15/13

    MANTADIX (amantadine), dopaminergique

    Avis favorable au maintien du remboursement dans la maladie de Parkinson et les syndromes parkinsoniens induits par les neur...
    icône flèche
  • 11/15/06

    MANTADIX (amantadine (chlorhydrate d’))

    MANTADIX (amantadine (chlorhydrate d’))
    icône flèche
Technical information
ATC code
  • N04BB01
Manufacturer
LABORATOIRE X.O
Presentation

MANTADIX 100 mg, capsule (code CIS : 67703803)
1 flacon(s) en verre brun de 50 capsule(s) (CIP : 34009 315 337 1 9)
Plaquette(s) aluminium PVC polyéthylène PVDC de 50 capsule(s) (CIP : 34009 302 359 4 2)

All our publications
    Central nervous system diseases Drug therapy Geriatrics Neurodegenerative diseases Poisoning Respiratory tract diseases - miscellaneous Vaccine Virus diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
TGczrQ8e7AK55GH6